Skip to main content
. 1997 Mar 18;94(6):2489–2494. doi: 10.1073/pnas.94.6.2489

Figure 3.

Figure 3

Tumor therapy of established lymph node B16-C215 tumors in TCR Vβ3 TG mice. Lymph nodes were microinjected with B16-C215 tumor cells and screened for tumor growth after 5 days. Mice with established tumor were selected for therapy. Accumulated data from two separate experiments with 19–20 animals in each group. Statistical significance of vehicle vs. fusion protein-treated animals was determined using the Mann–Whitney U test.